W.P. Burkard

Increase of Cerebral Catecholamines caused by 3,4-Dihydroxyphenylalanine after Inhibition of Peripheral Decarboxylase

G. Bartholini, W.P. Burkard, A. Pletscher et al. · Nature · 1967 · 243 citations

Neurophysiology, Neuroanatomy, Medicine +12

Benzodiazepine Antagonist Ro 15–1788: Binding Characteristics and Interaction with Drug‐Induced Changes in Dopamine Turnover and Cerebellar cGMP Levels

H. Möhler, W.P. Burkard, H. H. Keller et al. · Journal of Neurochemistry · 1982 · 223 citations

Psychopharmacology, Pharmacotherapy, Social Sciences +19

Neurochemical profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.

M. Da Prada, R. Kettler, H. H. Keller et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 199 citations

Blockade of central 5-hydroxytryptamine receptors by methiothepin

M. A. Monachon, W.P. Burkard, M Jalfre et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1972 · 143 citations

Central 5-Hydroxytryptamine Receptors, Medicine, Neuropeptide Receptor +4

CHLORINATED ARYLALKYLAMINES AFFECTING THE CEREBRAL METABOLISM OF 5-HYDROXYTRYPTAMINE

A. Pletscher, G. Bartholini, H. Bruderer et al. · Journal of Pharmacology and Experimental Therapeutics · 1964 · 128 citations